4th Quarter - Report
TODD STRATEGY GROUP for BAYER CORPORATION
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug pricing. H.R.5376 - Inflation Reduction Act of 2022. Chronic Kidney Disease. Device remanufacturing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL | — |
| JEFF LUCAS | — |
| DANIEL M TODD | — |
| NICHOLAS UEHLECKE | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.